Evidence map›Paper›PMID 32859730›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

B Cell αv Integrins Regulate TLR-Driven Autoimmunity.

Mridu Acharya, Fiona Raso, Sara Sagadiev, Emily Gilbertson, Lauren Kadavy, Quan Z Li, Mei Yan, Lynda M Stuart, Jessica A Hamerman, Adam Lacy-Hulbert

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mridu AcharyaImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101; macharya@benaroyaresearch.org adamlh@benaroyaresearch.org.
Fiona RasoImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0001-9677-5801
Sara SagadievImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0002-8371-0977
Emily GilbertsonImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Lauren KadavyImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0003-1683-7748
Quan Z LiDepartment of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-7257-0489
Mei YanDepartment of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Lynda M StuartImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Jessica A HamermanImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0001-5864-5299
Adam Lacy-HulbertImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101; macharya@benaroyaresearch.org adamlh@benaroyaresearch.org.ORCID 0000-0003-2162-0156
Virginia Mason Medical Center · USThe University of Texas Southwestern Medical Center · USGates Foundation · US

Funding

BCAP regulation of TLR7/9 signaling in LupusR01AI150178 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI HAMERMAN, JESSICA A · 2020 to 2024
$3.7M
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic ArthritisR01AR076242 · NIAMS · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI BARNES, BETSY J, HAMERMAN, JESSICA A · 2019 to 2023
$3.3M
Identification of Host Drug Development Targets in Influenza Using Transposon MutagenesisR33AI119341 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI LACY-HULBERT, ADAM · 2017 to 2019
$1.5M
Dendritic Cell Control of Intestinal T Cell ResponsesR01DK093695 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LACY-HULBERT, ADAM · 2012 to 2015
$1.4M
NIAID NIH HHS R01 AI150178NIAID NIH HHS R33 AI119341NIAMS NIH HHS R01 AR076242NIDDK NIH HHS R01 DK093695
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is defined by loss of B cell tolerance, resulting in production of autoantibodies against nucleic acids and other cellular Ags. Aberrant activation of TLRs by self-derived RNA and DNA is strongly associated with SLE in patients and in mouse models, but the mechanism by which TLR signaling to self-ligands is regulated remains poorly understood. In this study, we show that αv integrin plays a critical role in regulating B cell TLR signaling to self-antigens in mice. We show that deletion of αv from B cells accelerates autoantibody production and autoimmune kidney disease in the Tlr7.1 transgenic mouse model of SLE. Increased autoimmunity was associated with specific expansion of transitional B cells, extrafollicular IgG2c-producing plasma cells, and activation of CD4 and CD8 T cells. Our data show that αv-mediated regulation of TLR signaling in B cells is critical for preventing autoimmunity and indicate that loss of αv promotes escape from tolerance. Thus, we identify a new regulatory pathway in autoimmunity and elucidate upstream signals that adjust B cell activation to prevent development of autoimmunity in a mouse model.

Indexed as

AnimalsAutoantibodiesAutoimmunityB-LymphocytesCells, CulturedDisease Models, AnimalHumansImmunoglobulin GImmunomodulationIntegrin alphaVLupus Erythematosus, SystemicLymphocyte ActivationMembrane GlycoproteinsMiceMice, TransgenicToll-Like Receptor 7AutoantibodiesImmunoglobulin GIntegrin alphaVMembrane GlycoproteinsTlr7 protein, mouseToll-Like Receptor 7

Identifiers

PMID32859730
PMCPMC7504890
OpenAlexW3081975357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.